ASMB | Assembly BiosciencesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$19.92
+$0.41 (+2.10%)

Assembly Biosciences (ASMB) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $19.92 vs 50 $25.54 / 200 $27.10
Projection
No cross projected
Test
Cross test window open, no test bar yet
Last cross
Death cross 23 Oct 2026 ยท projected 29 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $20.13 vs 50 $28.48 / 200 $18.35
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 6 Oct 2025 ยท projected 12 bars out

4-hour as of 3 Nov 16:00 ET

Price
below both $19.92 vs 50 $21.23 / 200 $26.38
Projection
No cross projected
Test
No active test
Last cross
Death cross 7 Oct 2026 ยท projected 26 bars out

Cross history

23
crosses on record since 2018
11 golden12 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
23 Oct 2026Death moderatedaily29 bars outActive Cross Test
7 Oct 2026Death4-hour26 bars outNot tested
8 Sep 2026Golden steepdaily26 bars out3 bar cross test
20 Aug 2026Golden4-hour18 bars outNot tested
18 May 2026Death flatdaily2 bars out3 bar cross test

About ASMB

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$6.4M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.